POSTER SESSION I - STOWELL-ORBISON AWARDS COMPETITION
Monday, March 26, 2007   —  9:30 AM - 12:00 Noon
Convention Center, Exhibit Hall B - 1


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...

...then notice the 'Event Added' prompt
in the toolbar above as feedback:
 



GENITOURINARY PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
90 Prostatic Central Zone: High Grade Prostatic Intraepithelial Neoplasia and Carcinoma (602)
HQ Al-Moghrabi, EC Belanger, KT Mai - The Ottawa Hospital, and University of Ottawa, Ottawa, ON, Canada
Add
91 Pre-Biopsy Serum PSA and Highest Biopsy Gleason Score Remain Significant Predictors of Extra-Capsular Extension: A Study of 533 Radical Prostatectomies (612)
AA Bargaje, K Rycyna, G Venkataraman, RC Flanigan, EM Wojcik - Loyola University Medical Center, Maywood, IL; Loyola University Medical Center
Add
92 Examination of Osteopontin, Clusterin, Drg-1, BMP7, Survivin, p-Smad, and p-JNK Protein Expression in Adenocarcinoma of the Prostate (CaP) (614)
AM Bell, C Zhong, M Sturm, P Roy-Burman, MB Cohen - U. of Iowa, Iowa City; U. of Southern California, Los Angeles
Add
93 Secondary Prostatic Adenocarcinoma: A Cytopathological and Immunohistochemical Study of 59 Cases (617)
C Bicamumpaka, C Marginean, KT Mai - University of Ottawa and the Ottawa Hospital, Ottawa, Canada
Add
94 Grading of Papillary Urothelial Carcinoma: Significant Interobserver Variations and Survivin as a Useful Marker (631)
YB Chen, JJ Tu, J Kao, XK Zhou, YT Chen - Weill Medical College of Cornell University, New York, NY
Add
95 The Fusion of TMPRSS2: ERG and an Intronic Deletion Is Associated with Hereditary Prostate Cancer (688)
MD Hofer, R Kuefer, S Perner, C Maier, K Herkommer, T Paiss, F Demichelis, W Vogel, J Hoegel, AM Chinnaiyan, MA Rubin - Brigham and Women’s Hospital, Boston, MA; Urologic University Hospital Ulm, Ulm, Germany; University Hospital Ulm, Ulm, Germany; University of Michigan School of Medicine, Ann Arbor, MI
Add
96 Intracellular Signaling Via Tyrosine 1062 in Ret Mediates Proliferation of Spermatogonia (695)
M Jijiwa, K Kawai, N Asai, M Takahashi - Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
Add
97 Urothelial Carcinoma with an Inverted Growth Pattern May Be Distinguished from Inverted Papilloma by UroVision Fluorescence In Situ Hybridization and Immunohistochemistry (696)
TD Jones, S Zhang, A Lopez-Beltran, JN Eble, MT Sung, GT MacLennan, R Montironi, PH Tan, LA Baldridge, L Cheng - Indiana University School of Medicine, Indianapolis, IN; Cordoba University, Cordoba, Spain; Chang Gung Memorial Hospital-Kaohsiung Medical Center, and Chang Gung University College of Medicine, Kaohsiung, Taiwan; Case Western Reserve University, Cleveland, OH; School of Medicine, Polytechnic University of the Marche Region (Ancona), United Hospitals, Ancona, Italy; Singapore General Hospital, Singapore, Singapore
Add
98 Oxidative Stress; an Etiologic Factor of Prostate Cancer? A Tissue Microarray and Marker Study of Age, Race and Neoplastic Progression (703)
S Khayyata, G Yildirim Kupesiz, A Andea, S Sheng, D Grignon, W Sakr - Wayne State University, Karmanos Cancer, Detroit Medical Center, Detroit, MI; University of Alabama, Birmingham, AL
Add
99 Histogenesis of Sarcomatoid Urothelial Carcinoma of the Urinary Bladder: Evidence for a Common Clonal Origin with Divergent Differentiation (707)
M Kuhar, MT Sung, M Wang, GT MacLennan, JN Eble, PH Tan, A Lopez-Beltran, R Montironi, L Cheng - Indiana University School of Medicine, Indianapolis, IN; Chang Gung Memorial Hospital-Kaohsiung Medical Center, and Chang Gung University College of Medicine, Kaohsiung, Taiwan; Case Western Reserve University, Cleveland, OH; Singapore General Hospital, Singapore; Cordoba University, Cordoba, Spain; School of Medicine, Polytechnic University of the Marche Region (Ancona), United Hospitals, Ancona, Italy
Add
100 Squamous Cell Carcinoma of the Bladder: A Study of 55 Radical Cystectomy Cases (712)
N Lagwinski, DE Hansel - Cleveland Clinic, Cleveland, OH
Add
101 Myosin VI, a Mediator of the P53-Dependent Cell Survival Pathway, Is Overexpressed in Adenocarcinoma of the Prostate (718)
L Li, PA Bourne, JL Yao, PA di Sant’Agnese, Z Zhuang, C Yin, C Wu, J Huang - University of Rochester Medical Center, Rochester, NY; NINDS, National Institute of Health, Bethesda, MD
Add
102 Upregulation of MKK4, MKK6 and MKK7 during Prostate Cancer Progression (728)
TL Lotan, MB Lyon, D Huo, JB Taxy, CB Brendler, CW Rinker-Schaeffer, WM Stadler - University of Chicago, Chicago, IL
Add
103 Positive-Block Ratio in Radical Prostatectomy Specimens Is an Independent Predictor of Prostate-Specific Antigen Recurrence (737)
RA Marks, HQ Lin, MO Koch, L Cheng - Indiana University, Indianapolis, IN; Yale University, New Haven, CT
Add
104 Molecular Signature and Clinical Implications of TMPRSS2 and ETS Transcription Family Genes Fusions in a Surgical Cohort of American Men Treated for Clinically Localized Prostate Cancer (740)
R Mehra, S Tomlins, R Shen, L Wang, J Wei, K Pienta, D Ghosh, MA Rubin, A Chinniayan, RB Shah - The University of Michigan, Ann Arbor, MI; Brigham’s and Women’s Hospital, Boston, MA
Add
105 Molecular Genetic Evidence Supporting the Neoplastic Nature of Stromal Cells in “Fibrosis” after Chemotherapy for Testicular Germ Cell Tumors (746)
MJ Morton, S Zhang, M Wang, DD Davidson, J Huang, TD Jones, JJ Anagnostou, Jr, SD Beck, RS Foster, L Cheng - Indiana University, Indianapolis, IN; University of Rochester, Rochester, NY
Add
106 Morphological Features of TMPRSS2:ERG Fusion Prostate Cancer (748)
JM Mosquera, S Perner, F Demichelis, MD Hoffer, KD Mertz, P Paris, J Simko, C Collins, T Bismar, MA Rubin - Brigham and Women’s Hospital, Boston, MA; Harvard Medical School, Boston, MA; University of Ulm, Ulm, Germany; SRA Division & Bioinformatics Group, Povo, Trento, Italy; University of California, San Francisco, CA; McGill University, Montreal, QC, Canada; MIT and Harvard Medical School, Cambridge, MA; Dana Farber Harvard Comprehensive Cancer Center, Boston, MA
Add
107 Nucleophosmin, a Critical Regulator of Cell Proliferation, Is Overexpressed in Prostate Cancer (756)
P Nigwekar, C Wu, JL Yao, PA Bourne, J Li, Z Zhuang, PA di Sant’Agnese, DC Walters, J Huang - University of Rochester Medical Center, Rochester, NY; National Institute of Health, Bethesda, MD
Add
108 TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated with Invasion (769)
S Perner, J-M Mosquera, F Demichelis, MD Hofer, PL Paris, J Simko, C Collins, TA Bismar, AM Chinnaiyan, AM De Marzo, MA Rubin - Brigham & Women’s Hospital, Harvard Medical School, Boston, MA; University of Ulm, Ulm, Germany; Dana Farber Cancer Institute, Boston, MA; University of California, San Francisco, CA; McGill University Faculty of Medicine, Montreal, QC, Canada; Johns Hopkins University School of Medicine & Bloomberg School of Public Health, Baltimore, MD; ITC-Irst, Povo (Trento), Italy; University of Michigan Medical School, Ann Arbor, MI
Add
109 Chromosomal Analysis of Renal Cell Carcinomas with Mixed Histologic Patterns (775)
O Pozdnyakova, LM Hutchinson, B Banner - UMASS Memorial Medical Center, Worcester, MA
Add
110 Needle Biopsy DNA Ploidy Versus Gleason Score for the Prediction of Disease Recurrence in Prostate Cancer (777)
M Punar, CE Sheehan, B Varadarajalu, JS Ross - Albany Medical College, Albany, NY
Add
111 Histologic Landmarks That Define Extraprostatic Extension at the Prostatic Apex: Characteristics of Extraprostatic Tissue at the Apex as Dissected by Robotic Radical Prostatectomy (802)
SJ Sirintrapun, GP Paner, J Tomaszewski, N Narula, D Lee, T Ahlering, A Tewari, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; University of Pennsylvania, Philadelphia, PA; University of California-Irvine, Orange County, CA; Cornell University, New York, NY
Add
112 Inflammatory Myofibroblastic Tumor of Urinary Bladder: Immunohistochemical, Molecular, and Cytogenetic Characterization and Comparison (808)
WR Sukov, AW Carlson, BM Shearer, KL Grogg, JC Cheville, RP Ketterling - Mayo Clinic, Rochester, MN
Add
113 Atypical Spindle Cell Proliferations in Adipose Tissue Adjacent to Renal Cell Carcinomas, a Lesion Mimicking Well-Differentiated Liposarcoma (816)
MR Tanas, C Sthapanachai, A Oliveira, BP Rubin - University of Washington, Seattle, WA; Mayo Clinic, Rochester, MN
Add
114 Diagnostic Utility of Molecular Markers in Separating Renal Oncocytomas from Chromophobe Renal Cell Carcinomas (824)
AH Uihlein, SD Finkelstein, RS Saad, JL Lindner, JF Silverman, YL Liu - Allegheny General Hospital, Pittsburgh, PA; Pittsburgh, PA
Add
115 The Predictive Value of Cytogenetic Abnormalities in Urine Samples (826)
RJ Van Kirk, Jr, JF Tomashefski, Jr, M Chung-Park, A Khiyami - Case Western Reserve University/MetroHealth, Cleveland, OH
Add
116 Utility of Anti-Phosphorylated H2AX Antibody g-H2AX) in Diagnosing Metastatic Renal Cell Carcinoma (832)
MJ Wasco, RT Pu - University of Michigan, Ann Arbor, MI
Add
117 Utility of a Comprehensive Immunohistochemical Panel in the Differential Diagnosis of Spindle Cell Lesions of the Urinary Bladder (834)
D Westfall, AL Folpe, GP Paner, E Oliva, LC Goldstein, AM Gown, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; Mayo Clinic, Rochester, MN; Massachusetts General Hospital, Boston, MA; PhenoPath Laboratories, Seattle, WA
Add
118 Pathological Characterization of Residual Prostate Cancer in a High Risk Neoadjuvant Chemotherapy Surgical Model (836)
AJ Wu, J Friedman, M Hussain, RB Shah - University of Michigan Medical Center, Ann Arbor, MI
Add